Barbara Ryan, Director at Indivior Pharmaceuticals, Inc. (INDV), bought 16 shares at $31.09 ($497) on 2026-03-13, disclosed to the SEC on 2026-03-13.
Open-market purchase of $497 INDV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.09 | 8 | $249 | 50.0% |
| 2 | $31.09 | 8 | $249 | 50.0% |
| Total | $31.09 avg | 16 | $497 | 100% |
| Filing → |
| INKT | SELL | 2026-03-11 | $36K | — | Filing → |
| INKT | SELL | 2026-03-04 | $5K | — | Filing → |
| INDV | BUY | 2026-01-07 | $27K | — | Filing → |